Biomarkers are essential for the identification of disease states. There are no early diagnostic or prognostic markers for ALS. The purpose of this study is to identify a panel of biomarkers from blood or spinal fluid of ALS patients and to collect data to better understand disease progression.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Levels of ALS biomarkers in blood
Timeframe: After blood is collected from study subjects. Data will be analyzed at one year.
Levels of ALS biomarkers in CSF
Timeframe: After CSF is collected from study subject. Data will be analyzed at one year.